AB Pharma Ltd.
|AB Pharma Ltd. Patent applications|
|Patent application number||Title||Published|
|20160136134||ANTIVIRAL COMPOUNDS HIGHLY EFFECTIVE AS HCV-NS5A INHIBITOR - Provided are compounds antiviral compounds represented by formula Ia and Ib:||05-19-2016|
|20140364429||ANTIVIRAL COMPOUNDS HIGHLY EFFECTIVE AS HCV-NS5A INHIBITOR - Provided are compounds antiviral compounds represented by formula Ia and Ib:||12-11-2014|
|20140205567||Macrocyclic Heterocyclic Compound for Inhibiting Hepatitis C Virus and Preparation and Use Thereof - The present invention discloses a class of novel macro-heterocyclic compounds represented by the formula Ia or Ib, and their intermediates, preparation methods and the uses. The macro-heterocyclic compounds of the present invention have good inhibitory activities against hepatitis C virus (HCV), and can be used to treat HCV infection effectively by its excellent inhibition against HCV, low toxicity and side effects.||07-24-2014|
|20140005104||POLYHETEROCYCLIC COMPOUNDS HIGHLY POTENT AS HCV INHIBITORS||01-02-2014|
|20110183895||POLYHETEROCYCLIC COMPOUNDS HIGHLY POTENT AS HCV INHIBITORS - The present invention discloses the structure, preparation methods and uses of a series of novel polyheterocyclic based compounds (Ia-Ib and IIa-IIb) that are highly effective for inhibiting hepatitis C virus (HCV):||07-28-2011|
Patent applications by AB Pharma Ltd.